GNT Pharmaceuticals, Inc.

New Filing
CIK: 0002057459·Pharmaceuticals·DELAWARE·Filed: Mar 3, 2025
Total Offering

$150,000

Amount Sold

$0

Investors

0

First Sale

N/A

Offering Details

Type
Equity
Exemptions
Rule 506(b)
Entity Type
Corporation
Year Incorporated
2024
Non-Accredited Investors
No

Related Persons

NameRole
Phoebe Wood
Related Person
Larry Horn
Related Person
Serge Martinod
Related Person
Dale Boden
Related Person
Jim Corman
Related Person

Company

GNT Pharmaceuticals, Inc.

3711 QUAIL HOLLOW COURT

LOUISVILLE, KY, 40241

502-894-0295

SEC Filing

0002057459-25-000001

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.

Sign Up Free
GNT Pharmaceuticals, Inc. Form D Filing — $150,000 | FilingFlow